IL-6, a prominent cachexia-associated factor in pancreatic cancer [16], which was remarkably increased in the serum of Pan02 tumor-bearing mice, whereas that of the tumor naive mice was below the detection limit (Figure 4C). This evidence concerns the gene IL6 and Cachexia.